| RS1359105410 |
C12orf57
|
Health Risk |
Pathogenic |
Temtamy syndrome, Temtamy syndrome |
| RS1359106679 |
SUMF1
|
Health Risk |
Pathogenic |
Multiple sulfatase deficiency, Multiple sulfatase deficiency |
| RS1359108756 |
LAMA2
|
Health Risk |
Pathogenic |
LAMA2-related muscular dystrophy, LAMA2-related muscular dystrophy |
| RS1359109336 |
USH1G
|
Health Risk |
Pathogenic |
Usher syndrome type 1G, Usher syndrome type 1G |
| RS1359141230 |
SGCG
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive limb-girdle muscular dystrophy type 2C, Autosomal recessive limb-girdle muscular dystrophy type 2C |
| RS1359141531 |
FLNA
|
Health Risk |
Pathogenic |
Melnick-Needles syndrome, Heterotopia |
| RS1359152024 |
CUL7
|
Health Risk |
Likely pathogenic |
3-M syndrome, 3-M syndrome |
| RS1359164384 |
MED17
|
Health Risk |
Likely pathogenic |
— |
| RS1359166382 |
TTLL5
|
Health Risk |
Likely pathogenic |
— |
| RS1359172781 |
VWF
|
Health Risk |
Pathogenic |
von Willebrand disease type 3, von Willebrand disease type 3 |
| RS1359183911 |
GLI3
|
Health Risk |
Conflicting classifications of pathogenicity |
Greig cephalopolysyndactyly syndrome, Pallister-Hall syndrome |
| RS1359208225 |
KMT2C
|
Health Risk |
Pathogenic |
— |
| RS1359241037 |
DNAAF1
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia 13, Primary ciliary dyskinesia 13 |
| RS1359244955 |
MYO15A
|
Health Risk |
Pathogenic |
— |
| RS1359262571 |
TRIO
|
Health Risk |
Pathogenic |
— |
| RS1359277013 |
SLC24A5
|
Health Risk |
Pathogenic |
— |
| RS1359281521 |
GALC
|
Health Risk |
Conflicting classifications of pathogenicity |
Galactosylceramide beta-galactosidase deficiency, Galactosylceramide beta-galactosidase deficiency |
| RS1359321518 |
GDF1
|
Health Risk |
Pathogenic/Likely pathogenic |
Inborn genetic diseases, Heterotaxy |
| RS1359327577 |
CFTR
|
Health Risk |
Likely pathogenic |
Bronchiectasis with or without elevated sweat chloride 1, Bronchiectasis with or without elevated sweat chloride 1 |
| RS1359327847 |
JAK3
|
Health Risk |
Pathogenic |
T-B+ severe combined immunodeficiency due to JAK3 deficiency, T-B+ severe combined immunodeficiency due to JAK3 deficiency |
| RS1359334884 |
GZF1
|
Health Risk |
Pathogenic |
— |
| RS1359338583 |
RP1
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 1, Retinal dystrophy |
| RS1359346386 |
GFM1
|
Health Risk |
Pathogenic |
— |
| RS1359353262 |
PCSK1
|
Health Risk |
Likely pathogenic |
PCSK1-related disorder, PCSK1-related disorder |
| RS1359357677 |
TCF12
|
Health Risk |
Pathogenic |
— |
| RS1359361476 |
DHFR
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1359367948 |
GDAP1
|
Health Risk |
Likely pathogenic |
Charcot-Marie-Tooth disease axonal type 2K, Charcot-Marie-Tooth disease axonal type 2K |
| RS1359369718 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1359373777 |
INPP5E
|
Health Risk |
Pathogenic |
Joubert syndrome 1, Joubert syndrome 1 |
| RS1359376928 |
NRXN1
|
Health Risk |
Likely pathogenic |
Pitt-Hopkins-like syndrome 2, Pitt-Hopkins-like syndrome 2 |
| RS1359404443 |
MFRP
|
Health Risk |
Pathogenic |
Isolated microphthalmia 5, Isolated microphthalmia 5 |
| RS1359408831 |
FANCI
|
Health Risk |
Pathogenic/Likely pathogenic |
Fanconi anemia complementation group I, Fanconi anemia complementation group I |
| RS1359411004 |
MCEE
|
Health Risk |
Pathogenic |
Methylmalonic acidemia due to methylmalonyl-CoA epimerase deficiency, Methylmalonic acidemia due to methylmalonyl-CoA epimerase deficiency |
| RS1359437084 |
CPLANE1
|
Health Risk |
Pathogenic |
Joubert syndrome 17, Joubert syndrome 17 |
| RS1359437833 |
LARGE1
|
Health Risk |
Pathogenic |
Muscular dystrophy-dystroglycanopathy type B6, Muscular dystrophy-dystroglycanopathy type B6 |
| RS1359458155 |
SLC4A1
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS1359478892 |
RDH5
|
Health Risk |
Pathogenic |
— |
| RS1359479064 |
APOB
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypercholesterolemia, autosomal dominant |
| RS1359482508 |
HSD17B4
|
Health Risk |
Pathogenic/Likely pathogenic |
Bifunctional peroxisomal enzyme deficiency, Bifunctional peroxisomal enzyme deficiency |
| RS1359484392 |
UNC80
|
Health Risk |
Pathogenic |
Hypotonia, infantile |
| RS1359518284 |
ACADS
|
Health Risk |
Likely pathogenic |
— |
| RS1359522025 |
CEP290
|
Health Risk |
Conflicting classifications of pathogenicity |
Meckel-Gruber syndrome, Nephronophthisis |
| RS1359540820 |
PHKA2
|
Health Risk |
Pathogenic |
Glycogen storage disease IXa1, Glycogen storage disease IXa1 |
| RS1359551200 |
MRE11
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1359574944 |
KAT6A
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1359575116 |
ELAC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Combined oxidative phosphorylation defect type 17, Combined oxidative phosphorylation defect type 17 |
| RS1359577297 |
MADD
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1359582686 |
TAOK1
|
Health Risk |
Pathogenic |
TAOK1-related disorder, TAOK1-related disorder |
| RS1359585490 |
STX3
|
Health Risk |
Pathogenic |
Retinal dystrophy and microvillus inclusion disease, Retinal dystrophy and microvillus inclusion disease |
| RS1359599082 |
BRPF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual developmental disorder with dysmorphic facies and ptosis, Inborn genetic diseases |
| RS1359602238 |
TECPR2
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary spastic paraplegia 49, Hereditary spastic paraplegia 49 |
| RS1359618876 |
PCNT
|
Health Risk |
Pathogenic |
Microcephalic osteodysplastic primordial dwarfism type II, Microcephalic osteodysplastic primordial dwarfism type II |
| RS1359621977 |
CRB1
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa 12, Leber congenital amaurosis 8 |
| RS1359631755 |
PAX1
|
Health Risk |
Pathogenic |
— |
| RS1359635065 |
DOK7
|
Health Risk |
Likely pathogenic |
Fetal akinesia deformation sequence 3, Fetal akinesia deformation sequence 3 |
| RS1359661881 |
UNC13D
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial hemophagocytic lymphohistiocytosis 3, See cases |
| RS1359687163 |
PSMB8
|
Health Risk |
Pathogenic |
Proteasome-associated autoinflammatory syndrome 1, Proteasome-associated autoinflammatory syndrome 1 |
| RS1359713084 |
USH2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa, Usher syndrome type 2A |
| RS1359760798 |
AGXT
|
Health Risk |
Likely pathogenic |
Primary hyperoxaluria, type I |
| RS1359774813 |
DHCR7
|
Health Risk |
Conflicting classifications of pathogenicity |
Smith-Lemli-Opitz syndrome, Smith-Lemli-Opitz syndrome |
| RS1359777462 |
FIG4
|
Health Risk |
Likely pathogenic |
FIG4-related disorder, FIG4-related disorder |
| RS1359798259 |
EMC1
|
Health Risk |
Pathogenic |
— |
| RS1359810808 |
NDUFAF5
|
Health Risk |
Conflicting classifications of pathogenicity |
Mitochondrial complex I deficiency, nuclear type 16 |
| RS1359811582 |
ADGRV1
|
Health Risk |
Conflicting classifications of pathogenicity |
Usher syndrome type 2C, Usher syndrome type 2C |
| RS1359827243 |
MTR
|
Health Risk |
Likely pathogenic |
MTR-related disorder, MTR-related disorder |
| RS1359844902 |
EEF1A2
|
Health Risk |
Likely pathogenic |
EEF1A2-related developmental and degenerative epileptic-dyskinetic encephalopathy, EEF1A2-related developmental and degenerative epileptic-dyskinetic encephalopathy |
| RS1359847895 |
NDUFAF5
|
Health Risk |
Pathogenic/Likely pathogenic |
Mitochondrial complex I deficiency, nuclear type 16 |
| RS1359856569 |
ABCC6
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS1359874667 |
ALMS1
|
Health Risk |
Pathogenic |
Alstrom syndrome, Alstrom syndrome |
| RS1359876093 |
VPS13A
|
Health Risk |
Likely pathogenic |
— |
| RS1359892832 |
OPTN
|
Health Risk |
Pathogenic |
Primary open angle glaucoma, Amyotrophic lateral sclerosis type 12 |
| RS1359896342 |
DDX11
|
Health Risk |
Likely pathogenic |
— |
| RS1359922150 |
CYP19A1
|
Health Risk |
Pathogenic |
— |
| RS1359968264 |
NEFH
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease axonal type 2CC, Charcot-Marie-Tooth disease axonal type 2CC |
| RS1359975493 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1359982302 |
UBE3B
|
Health Risk |
Pathogenic |
— |
| RS1359984033 |
COMP
|
Health Risk |
Pathogenic |
Pseudoachondroplastic spondyloepiphyseal dysplasia syndrome, Pseudoachondroplastic spondyloepiphyseal dysplasia syndrome |
| RS1360000258 |
PDE6B
|
Health Risk |
Pathogenic |
— |
| RS1360001006 |
PEX6
|
Health Risk |
Conflicting classifications of pathogenicity |
Peroxisome biogenesis disorder, Peroxisome biogenesis disorder |
| RS1360001910 |
SLC26A3
|
Health Risk |
Likely pathogenic |
— |
| RS1360003941 |
HOXB13
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1360058966 |
POLR3B
|
Health Risk |
Likely pathogenic |
Thyroid cancer, nonmedullary |
| RS1360071443 |
GP1BB
|
Health Risk |
Pathogenic |
Macrothrombocytopenia, Thrombocytopenia |
| RS1360092016 |
COL3A1
|
Health Risk |
Likely pathogenic |
Ehlers-Danlos syndrome, type 4 |
| RS1360128571 |
INTU
|
Health Risk |
Likely pathogenic |
Short rib-polydactyly syndrome, Short-rib thoracic dysplasia 20 with polydactyly |
| RS1360142371 |
PLEC
|
Health Risk |
Pathogenic |
Epidermolysis bullosa simplex 5C, with pyloric atresia |
| RS1360145032 |
NEK1
|
Health Risk |
Likely pathogenic |
Short-rib thoracic dysplasia 6 with or without polydactyly, Short-rib thoracic dysplasia 6 with or without polydactyly |
| RS1360157605 |
PCNT
|
Health Risk |
Pathogenic |
— |
| RS1360158770 |
BRCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary breast ovarian cancer syndrome, Hereditary cancer-predisposing syndrome |
| RS1360167769 |
FLNC
|
Health Risk |
Pathogenic |
Distal myopathy with posterior leg and anterior hand involvement, Hypertrophic cardiomyopathy 26 |
| RS1360208732 |
CYP11B1
|
Health Risk |
Likely pathogenic |
Deficiency of steroid 11-beta-monooxygenase, Deficiency of steroid 11-beta-monooxygenase |
| RS1360212575 |
YARS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurodevelopmental delay, Charcot-Marie-Tooth disease dominant intermediate C |
| RS1360258103 |
USH2A
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 39, Usher syndrome type 2A |
| RS1360260127 |
FAT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1360260333 |
EVC2
|
Health Risk |
Likely pathogenic |
Ellis-van Creveld syndrome, Curry-Hall syndrome |
| RS1360260625 |
POT1
|
Health Risk |
Likely pathogenic |
Tumor predisposition syndrome 3, Tumor predisposition syndrome 3 |
| RS1360278309 |
TUBGCP4
|
Health Risk |
Likely pathogenic |
— |
| RS1360279030 |
PTCH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Gorlin syndrome |
| RS1360279134 |
ATP7B
|
Health Risk |
Pathogenic/Likely pathogenic |
Wilson disease, Inborn genetic diseases |
| RS1360282089 |
RARS2
|
Health Risk |
Pathogenic/Likely pathogenic |
Pontocerebellar hypoplasia type 6, Pontocerebellar hypoplasia type 6 |